Drug – bio-affecting and body treating compositions – Plant material or plant extract of undetermined constitution... – Containing or obtained from cinnamomum
Reexamination Certificate
2011-08-23
2011-08-23
Tate, Christopher R. (Department: 1655)
Drug, bio-affecting and body treating compositions
Plant material or plant extract of undetermined constitution...
Containing or obtained from cinnamomum
C514S554000, C514S565000
Reexamination Certificate
active
08003141
ABSTRACT:
Materials derived from cinnamon can be administered orally to humans or animals for the purpose of controlling blood glucose as well improving glucose tolerance. Controlling glucose metabolism is essential for those with impaired glucose metabolism as is the case for those with Type II diabetes where insulin function is not properly functioning. Such administration can also be used for the purpose of enhancing nutrient transport for purposes of athletic performance and controlling bodyweight and body fat levels. Similarly related, such administration can also be used for the purpose of enhancing creatine transport into excitable tissues such as skeletal muscle. The material can be administered as extracts of cinnamon and can be administered in a variety of ways including capsules, tablets, powdered beverages, bars, gels or drinks.
REFERENCES:
patent: 5900435 (1999-05-01), Meglasson
patent: 5968900 (1999-10-01), Greenhaff et al.
patent: 6051236 (2000-04-01), Portman
patent: 6136339 (2000-10-01), Gardiner et al.
patent: 6172114 (2001-01-01), McCabe
patent: 6200569 (2001-03-01), Cheng et al.
patent: 6485773 (2002-11-01), Myers et al.
patent: 6903136 (2005-06-01), Miller et al.
patent: 2001/0008641 (2001-07-01), Krotzer
patent: 2001/0022980 (2001-09-01), Bell et al.
patent: 2003/0224062 (2003-12-01), Miller et al.
patent: 2004/0028751 (2004-02-01), Mae et al.
patent: 2004/0043013 (2004-03-01), McCleary
patent: 2004/0224035 (2004-11-01), Miller et al.
patent: 2005/0281896 (2005-12-01), Gardiner et al.
patent: 2006/0275294 (2006-12-01), Omoigui
patent: 2006/0280614 (2006-12-01), Quell et al.
patent: 2006/0280814 (2006-12-01), Gardiner et al.
patent: 2008/0063689 (2008-03-01), Farber
Green et al “Carbohydrate ingestion augments creatine retention during creatine feeding in humans ”Acta Physiol Scand (1996) 158, pp. 195-202.
A.L. Green, E. Hultman, I.A. MacDonald, D.A. Sewell and P.L. Greenhaff, “Carbohydrate ingestion augments skeletal muscle creatine accumulation during creatine supplementation in humans,” 1996, American Journal of Physiology, 271 (5): E821-E826.
R.A. Anderson, C.L. Broadhurst, M.M. Polansky, W.F Schmidt, A. Khan, V.P. Flanagan, N.W. Schoene and D.J. Graves, “Isolation and Characterization of Polyphenol Type-A Polymers from Cinnamon with Insulin-like Biological Activity,” 2004, Journal of Agricultural and Food Chemistry, 52: 65-70.
C. L. broadhurst, M.M. Polansky and R.A. Anderson, “Insulin-like Biological Activity of Culinary and Medicinal Plant Aqueous Extracts in Vitro,” 2000, J. Agric, Food Chem, 48 (3): 849-852.
M. D. Althuis, N.E. Jordan, E.A. Ludington and J.T. Wittes, “Glucose and insulin responses to dietary chromium supplements: a meta-analysis, ” 2002, Am J. Clin Nutr, 76 (1): 148-155.
G. R. Steenge, J. Lambourne, A. Casey, I.A. MacDonald and P.L. Greenhaff, “Stimulatory effect of insulin on creatine accumulation in human skeletal muscle,” 1998, Am. J. Physiol. 275 (38): E974-E979.
S. I. Kreydiyyeh, J. Usta and R. Copti, “Effect of cinnamon, clove and some of their constituents on the Na+−K+−ATPase activity and alanine absorption in the rat jejunum,”2000, Food and Chemical Toxicology 38 (9): 755-762.
K.J. Jarvill-taylor, Ph.D., R.A. Andersson, Ph.D., and D.J. Graves, Ph.D.,“A Hydroxychalcone Derived from Cinnamon Functions as a Mimetic for Insulin in 3T3-L11 Adipocytes,” 2001, Journal of the American College of Nutrition, 20 (4): 327-336.
A. Khan, N.A. Bryden, M.M. Polansky and R.A. Anderson, “Insulin Potentiating Factor and Chromium Content of Selected Foods and Spices,” 1990, Biological Trace Element Research, 24 (3): 183-188.
J. McBride,“Cinnamon Extracts Boost Insulin Sensitivity, ”Jul. 2000, Agricultural Research, p. 21.
Y. Huang and S.H. Ho, “Toxicity and Antifeedant Activities of Cinnamaldehyde Against the Grain Storage Insects,Tribolium castaneum Herbst) andSitophilus zeamaisMotsch,” 1998, J. Stored Prod. Res., 34 (1): 11-17.
S. Onderoglu, S. Sozer, K.M. Erbil, R. Ortac and F. Lermioglu, “The Evaluation of Long-term Effects of Cinnamon Bark and Olive Leaf on Toxicity induced by Streptozotocin Administration to Rats,” 1999, J. Pharm. Pharmacol, 51(11): 1305-1312.
N. Cheng, N. Cheng, X. Zhang, Y-D,I. Chen, B.J. Stoecker, and R.A. Anderson, Hypoglycemic Effects of Cinnamon, Heshouwu & Mushroom Extracts in Type 2 Diabetes Mellitus, @2002, FASEB J., Experimental Biology 2002: Meeting Abstracts, 16: A647.
J. Imparl-Radosevich, S. Deas, M.M. Polansky, D.A. Baedke, T.S. Ingebritsen, R.A. Anderson an D. J. Graves, “Regulation of PTP-1 and Insulin Receptor Kinase by Fractions from Cinnamon: Implications fro Cinnamon Regulation of Insulin Signalling,” 1998, Horm Res, 50 (3): 177-182.
J. Mancini-Filho, A. Van-Koiij, D.A.P. Mancini, F.F. Cozzolino and R.P. Torres, “Antioxidant activity of cinnamon (Cinnamomum Zeylanicurn,.Breyne) extracts,” 1998, Bollettino Chimico Famaceutico, 137 (11): 443-447.
Miller Peter
Romero Timothy
Gifford Krass Sprinkle Anderson & Citkowski P.C.
Integrity Nutraceuticals
Tate Christopher R.
LandOfFree
Dietary supplements containing extracts of cinnamon and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Dietary supplements containing extracts of cinnamon and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Dietary supplements containing extracts of cinnamon and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2788578